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Summary. The incidence of adenocarcinoma of the 
distal esophagus is rapidly increasing in the Western 
world. The histopathological sequence of (Barrett's) 
metaplasia, which develops as a consequence of chronic 
reflux, to dysplasia and then to carcinoma is well 
established for these tumors. In Barrett's esophagus a 
variety of molecular changes have been characterized 
and correlated with tumor initiation and progression. 
Among the early changes in premalignant stages of 
metaplasia are alterations of the transcripts of FHIT, a 
presumptive tumor suppressor gene which spans the 
common fragile site FRA3B. Mutations of p53 seem to 
accumulate mainly in the transition from low to high 
grade dysplasia. Inactivation of other tumor suppressor 
genes by mutation (APC, p16) or hypermethylation 
(p16) as well as amplification of oncogenes such as c- 
erbB2 are relatively late events in the development of 
adenocarcinoma. Among the phenotypic changes in 
Barrett's esophagus are an expansion of the Ki67 
proliferation compartment which correlates with the 
degree of dysplasia. Moreover, accumulation of rabl l  
molecules which are involved in membrane trafficking 
has been reported to be specific for the loss of polarity 
seen in low grade dysplasia. Reduced expression of the 
cadherinlcatenin complex as  well as  increased 
expression of various proteases develop chiefly in 
invasive carcinomas. Despite the progress that has been 
made in the identification of molecular markers in 
Barrett's carcinoma, to date the histopathogical 
diagnosis of high grade dysplasia in endoscopic biopsies 
remains the best predictor of invasive cancer. Immuno- 
histochemistry applying a panel of antibodies including 
p53, Mib- l  or r a b l l  can be helpful to diagnose 
regenerative metaplastic epithelium or low and high 
grade dysplasia. 
Key words: Esophagus, Metaplasia, Dysplasia, 
Carcinoma, Molecular genetics 
Offprint requests to: Prof. Dr. med. Martin Werner, lnstitut fiir 
Allgemeine Pathologie und Pathologische Anatomie der Technischen 
Universitat Miinchen, Klinikurn rechts der Isar, lsrnaninger Str. 22, D- 
81 675 Munich, Germany 
Introduction 
As a result of chronic duodeno-gastro-esophageal 
reflux the normal squamous epithelium in the distal 
esophagus is replaced by a columnar or intestinalized 
epithelium with goblet cells (Spechler and Goyal, 1986; 
Stein and Panel of experts, 1998). This metaplastic 
(Barrett's) epithelium is a predisposing condition for the 
development of adenocarcinoma, through a well defined 
histopathological sequence from metaplasia to low grade 
dysplasia to high grade dysplasia and then to carcinoma. 
The risk for developing adenocarcinoma is estimated to 
be increased 30-125-fold in patients with Barrett's 
metaplasia vs. comparison populations without Barrett's 
metaplasia. In the Western world, Barrett's adeno- 
carcinoma has the most rapidly increasing incidence 
among all malignancies (Blot et al., 1991; Altorki et al., 
1997'1. 
f h e  esophagus is easily accessible for endoscopic 
surveillance, and periodic examination with systematic 
biopsies has been proposed in Barrett's esophagus 
patients to identify those with an increased risk for 
cancer (Levine et al., 1993). So far, the best predictor of 
carcinoma is the histopathological detection of high 
grade dysplasia, since it is known that there is a high 
incidence of invasive cancer which is either coincident 
or develops within a short time (McArdle et al., 1992). 
However, the histopathological grading of dysplasia in 
endoscopic biopsies from Barrett 's  esophagus is 
subjective and has a relatively high interobserver 
disagreement. Therefore, high-grade dysplasia, which in 
most centers  is an indication for "prophylactic 
esophagectomy", should be confirmed by two 
experienced pathologists (Pera et al., 1992; Rusch et al., 
1994). Recently, the assessment of cytometric and 
morphometric features has been proposed as a valuable 
adjunct for clinical decision-making in cases of Barrett's 
esophagus with dysplasia (Polkowski et al., 1998). 
In addition to histomorphology there may be other 
criteria for recognizing Barrett's esophagus patients with 
a significant risk for developing cancer. During the 
multistep process of neoplastic transformation, gross 
chromosomal changes occur. Accompanying genetic 
alterations lead to abnormalities in gene expression and 






